Your SlideShare is downloading. ×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Eyelash Growth Pg Analogs Bauman Ishrs09 Finalforshare

1,065
views

Published on

In December of 2008, the FDA approved the first medication for eyelash growth, called Latisse (Allergan) containing Bimatoprost a prostaglandin F2a analog. This presentation discusses the basics of …

In December of 2008, the FDA approved the first medication for eyelash growth, called Latisse (Allergan) containing Bimatoprost a prostaglandin F2a analog. This presentation discusses the basics of the research which led to the approval including side effects and off-label uses (like scalp hair growth). Presented by Alan J. Bauman MD at the International Society of Hair Restoration Surgery's Annual Scientific Meeting, Amsterdam, The Netherlands, July 2009.

Published in: Health & Medicine, Travel

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,065
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
13
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. FDA-Approval of Bimatoprost for
    Eyelash Growth
    Alan J. Bauman, M.D.
    Diplomate, American Board of Hair Restoration Surgery
    ISHRS Annual Meeting / Amsterdam 2009
  • 2. Disclosures / COI
    The following potential conflict of interest relationships are germane to my presentation: NONE
    FDA-approved & non-FDA approved indications will be discussed
    2
  • 3. Overview
    Eyelashes & Eyelash Hypotrichosis
    Prostaglandin Analogs
    Latisse™ (bimatoprost 0.03%)
    Clinical Studies
    Photographic Results
    Side Effects
    Off-Label Use
    3
  • 4. Prostaglandin Analogs
    Travoprost (Travatan)
    Latanoprost (Xalatan)
    Bimatoprost (Lumigan / Latisse)
    Intraocular Pressure-lowering Agents
    No systemic side effects
    Increase in length, thickness, pigmentation, number of lashes
    Eyelid skin darkening
    Eye irritation
    bimatoprost
    travoprost
    latanoprost
    4
  • 5. (Bimatoprost 0.03%)
    5
    5.
    1.
    4.
    2.
    3.
  • 6. Results: Primary Efficacy Endpoint
    Number (%) of subjects with ≥ 1-grade increase from baseline in Global Eyelash Assessment
    6
  • 7. Results:‘before’&‘After’16 wks
    7
  • 8. Side Effects
    • Itching sensation in the eye ~4%
    • 9. Eye redness
    • 10. Hair growth outside of target area
    • 11. Eyelid skin darkening
    • 12. Eye irritation
    • 13. Potential for iris darkening*
    • 14. Intraocular pressure effects
    8
  • 15. 16 wks x PG Analog + Tint + Perm:
    9
  • 16. Off-Label Bimatoprost Use: Scalp
    BEFORE AFTER: 8wks
    10
  • 17. 11
    References
    1.International Society of Hair Restoration Surgery. 2007 Practice Census Survey; Available at: http://www.ishrs.org/PDF/ISHRS_Practice_Census_Survey_Report_2007.pdf.
    2. Website: www.ishrs.org/mediacenter/media-statistics.htm. Accessed January 2009.
    3. American Society of Plastic Surgeons. 2000/2004/2005 National plastic surgery statistics. Cosmetic Hair Transplantation and reconstructive procedure trends. http://www.plasticsurgery.org/media/statistics/loader.cfm?url=/commonspot/security/getfile.cfm&;PageID=17870. Accessed January 31, 2007.
    4. Breeling J, Gandelman M. ‘‘Eyelash transplantation: who, why and how.’’ January 2007. International Society of Hair Restoration Surgery. http://www.ishrs.org/articles/eyelashtransplantation.htm. Accessed April 2007.
    5. Krusius FF. Ueber die EinplflanzungLebenderHaarezurWimpernbildung. Dtch Med Wochenschr. 1914; 19:958.
    6. Knapp P. KlinMblAugenheilk. 1917; 59:447.
    7. Sasagawa M. Hair transplantation. Jpn J Dermatol. 1930; 30:493.
    8. Fujita K. Reconstruction of eyebrows. La Lepro 1953; 22:364.
    9. Marritt, E. Transplantation of single hairs from the scalp as eyelashes. Review of the literature and a case report. J Dermatol Surg Oncol. 1980; 6(4):271–273.
    10. Flowers RS. ‘‘Pluck and Sew’’ individual hair follicle placement. American Society of Aesthetic Plastic Surgery, Orlando FL, April 1980. Caputy GG, Flowers RS. The ‘‘pluck and sew’’ technique of individual hair follicle placement. PlastReconstr Surg. 1994; 93(3): 615–620.
    11. Gandelman, M. Hair Transplantation, 2nd Ed, Walter Unger, MD (ed.).
    12. Herna´ndez-Zendejas G., Guerrerosantos J. Eyelash reconstruction and aesthetic augmentation with strip composite sideburn graft. PlastReconstr Surg. 1998 Jun; 101(7):1978–1980.
    13. Gandelman M. Single follicles harvested from donor area and inserted through a curved 18g needle placed into the lid. ISHRS Regional Live SurgeryWorkshop on Eyelash Transplantation, Los Angeles CA, October 23, 2006.
    14. Choi YC, Kim JC. ‘‘Single hair transplantation using the Choi hair transplanter. ’’ J Dermatol Surg Oncol. 1992; 18:945–948.
    15. Gandelman M. ‘‘Reverse follicular extraction’’ Hair Transplant Forum Intl. November/December 2004; 14(6):197, 203.
    16. Martinick J. ISHRS Regional Live Surgery Workshop on Eyelash Transplantation, Los Angeles CA, October 23, 2006.
    17. Martinick J. Direct placement of grafts into overlapping coronal slits in the eyelid; ISHRS Regional Live Surgery Workshop on Eyelash Transplantation, Los Angeles CA, October 23, 2006.
    18. Lee EW, Tucker NA. Pain associated with local anesthetic injection in eyelid procedures: comparison of microprocessor controlled versus traditional techniques. OphthalPlastReconstr Surg. 2007; January– February; 23(1):37–38.
    19. Johnstone M. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol. 1997; 124:544–547.
    20. Stober B, Potash S, Grossman M. Eyelash hypertrichosis in a patient treated with topical latanoprost. Cutis 2001; 67:109–110.
    21. Hollo G. The side effects of the prostaglandin analogues. Expert Opin Drug Saf. 2007; 6(1):45–52.
    22. Wand M. Latanaprost and hyperpigmentation of eyelashes. Arch Ophthalmol. 1997; 115:1206–1208.
  • 18. Thank You!doctorb@baumanmedical.comwww.eyelash-transplant.comwww.baumanmedical.comhttp://www.twitter.com/DrAlanBauman
    12